Arcus Biosciences, Inc. RCUS
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Asthika Goonewardene | Truist Financial | 14.48 $ | 39 $ | 24.52 % | 07/10/2025 |
| Eva Fortea Verdejo | Wells Fargo | 8.12 $ | 26 $ | 17.88 % | 07/05/2025 |
| Yigal Nochomovitz | Citigroup | 17.415 $ | 46 $ | 28.59 % | 24/10/2024 |
| Emily Bodnar | H.C. Wainwright | 18.44 $ | 20 $ | 1.56 % | 21/10/2024 |
| Judah Frommer | Morgan Stanley | 18.08 $ | 35 $ | 16.92 % | 08/10/2024 |
| Eva Fortea Verdejo | Wells Fargo | 18.08 $ | 29 $ | 10.92 % | 08/10/2024 |
| Jason Zemansky | Bank of America Securities | 13.69 $ | 23 $ | 9.31 % | 09/08/2024 |
| Peter Lawson | Barclays | 14 $ | 25 $ | 11.00 % | 08/07/2024 |
| Asthika Goonewardene | Truist Financial | 16.45 $ | 44 $ | 27.55 % | 24/06/2024 |
| Peter Lawson | Barclays | 16.15 $ | 35 $ | 18.85 % | 04/06/2024 |
| Robert Driscoll | Wedbush | 24.01 $ | 42 $ | 17.99 % | 11/05/2022 |